ANAPTYSBIO, INC. Property, Plant and Equipment, Gross
ANAPTYSBIO, INC. (ANAB) had Property, Plant and Equipment, Gross of $8.55 million as of 2026-03-31, per its 10-Q filed 2026-05-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-05-12
- 2026-03-31: Property, Plant and Equipment, Gross $8.55M.
- 2025-12-31: Property, Plant and Equipment, Gross $8.51M.
- 2025-09-30: Property, Plant and Equipment, Gross $8.51M.
- 2025-06-30: Property, Plant and Equipment, Gross $8.50M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-03-31 | $8.55M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $8.51M 10-Q · filed 2026-05-12 |
| 2025-09-30 | $8.51M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $8.50M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $8.47M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $8.45M 10-K · filed 2026-03-03 |
| 2024-09-30 | $8.20M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $8.35M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $8.31M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $8.32M 10-K · filed 2025-02-27 |
| 2023-09-30 | $8.32M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $7.93M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $7.72M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $7.67M 10-K · filed 2024-03-11 |
| 2022-09-30 | $7.38M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.31M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $7.25M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $7.21M 10-K · filed 2023-03-01 |
| 2021-09-30 | $7.18M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $7.72M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $6.82M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $6.73M 10-K · filed 2022-03-07 |
| 2020-09-30 | $6.66M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $6.43M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $6.41M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $6.30M 10-K · filed 2021-02-25 |
| 2019-09-30 | $6.25M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $5.91M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $5.89M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $5.64M 10-K · filed 2020-03-02 |
| 2018-09-30 | $5.44M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $5.16M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $4.69M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $4.64M 10-K · filed 2019-02-28 |
| 2017-09-30 | $4.44M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $4.43M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $4.41M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $4.27M 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |